STAT3 and cancer: While the relationship between STAT3 activity in DCs in human cancers and the accumulation of immunosuppressive Tregs has yet to be demonstrated, there is evidence of an inverse correlation between STAT3 inhibition in DCs and reduction of the Tregs in the tumor microenvironment from studies in preclinical mouse tumor models [7,33,37,38].